"BMS" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonBMS, J&J factor in HCP education on clot-busting mechanism before milvexian data drop - Fierce Ph...
BMS, J&J factor in HCP education on clot-busting mechanism before milvexian data drop Fierce Pharma
BMS Teacher of the Year arrested again on child sex abuse charges - KATC
BMS Teacher of the Year arrested again on child sex abuse charges KATC
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D - Ph...
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D PharmTech.com
Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s - statnews.com
Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s statnews.com
About us - Bristol Myers Squibb
About us Bristol Myers Squibb
BMS pens $850M solid tumor pact with T-cell engager biotech Janux - Fierce Biotech
BMS pens $850M solid tumor pact with T-cell engager biotech Janux Fierce Biotech
BMS Confident Its New Drugs Will Grow More Than Its Old Ones Shrink - Citeline News & Insights
BMS Confident Its New Drugs Will Grow More Than Its Old Ones Shrink Citeline News & Insights
Braemar Confirms Total Voting Rights at Just Over 33 Million Shares - The Globe and Mail
Braemar Confirms Total Voting Rights at Just Over 33 Million Shares The Globe and Mail
BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments - BioSpace
BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments BioSpace
Custom 11.1V 10.4Ah High Capacity Li-ion Battery Pack with BMS for Electric Devices & Industrial ...
Custom 11.1V 10.4Ah High Capacity Li-ion Battery Pack with BMS for Electric Devices & Industrial Applications Global Sources
Johnson & Johnson sued by BMS subsidiary in UPC’s first CAR-T patent dispute - IAM Media
Johnson & Johnson sued by BMS subsidiary in UPC’s first CAR-T patent dispute IAM Media
Bristol Motor Speedway’s Band of NASCAR Brothers - Speedway Digest
Bristol Motor Speedway’s Band of NASCAR Brothers Speedway Digest
BMS Teacher of the Year arrested on child sex abuse charges - KATC
BMS Teacher of the Year arrested on child sex abuse charges KATC
Transparency & reporting - Bristol Myers Squibb
Transparency & reporting Bristol Myers Squibb
Pharmaceutical research and development pipeline - Bristol Myers Squibb
Pharmaceutical research and development pipeline Bristol Myers Squibb
Worldwide locations - Bristol Myers Squibb
Worldwide locations Bristol Myers Squibb
Areas of interest - Bristol Myers Squibb
Areas of interest Bristol Myers Squibb
Global Inclusion - Bristol Myers Squibb
Global Inclusion Bristol Myers Squibb
Become a business supplier - Bristol Myers Squibb
Become a business supplier Bristol Myers Squibb
Our research in immunology - Bristol Myers Squibb
Our research in immunology Bristol Myers Squibb
JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff - Clinical Trials Arena
JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff Clinical Trials Arena
Global Patient Week - Bristol Myers Squibb
Global Patient Week Bristol Myers Squibb
Independent research - Bristol Myers Squibb
Independent research Bristol Myers Squibb
Our technologies - Bristol Myers Squibb
Our technologies Bristol Myers Squibb
BMS Names Dr. Harald Hampel SVP, Global Neuroscience Head - Contract Pharma
BMS Names Dr. Harald Hampel SVP, Global Neuroscience Head Contract Pharma
Bristol Myers Squibb Introduces "Change the Target. Change What’s Possible.” to Highlight Unmet N...
Champions in Care - Bristol Myers Squibb
Champions in Care Bristol Myers Squibb
Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B - Fierce ...
Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B Fierce Biotech
Doctorx Unscripted Bold Conversations about Patient-Driven Science - Bristol Myers Squibb
Doctorx Unscripted Bold Conversations about Patient-Driven Science Bristol Myers Squibb
Our research in neuroscience - Bristol Myers Squibb
Our research in neuroscience Bristol Myers Squibb
Chris Shibutani, MD - Bristol Myers Squibb
Chris Shibutani, MD Bristol Myers Squibb
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy...
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL) Bristol Myers Squibb
Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immun...
BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour - BioSpace
BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour BioSpace
Business development leadership team - Bristol Myers Squibb
Business development leadership team Bristol Myers Squibb
BMS' Cobenfy TV ad is latest target of FDA untitled letter spree - Fierce Pharma
BMS' Cobenfy TV ad is latest target of FDA untitled letter spree Fierce Pharma
BMS Students Selected for Honors Choir - TAPinto
Driving patient-centric care through global patient outreach - Bristol Myers Squibb
Driving patient-centric care through global patient outreach Bristol Myers Squibb
A global journey through BMS’ R&D hubs - Bristol Myers Squibb
A global journey through BMS’ R&D hubs Bristol Myers Squibb
Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb
Science Firsthand: The renaissance of neuroscience R&D Bristol Myers Squibb
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients - ...
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients Fierce Pharma
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line - BioSpace
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line BioSpace
New RayzeBio hub accelerates next-gen cancer therapies - Bristol Myers Squibb
New RayzeBio hub accelerates next-gen cancer therapies Bristol Myers Squibb
Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing - Fierce Pharma
Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing Fierce Pharma
The Bristol Myers Squibb Foundation - Bristol Myers Squibb
The Bristol Myers Squibb Foundation Bristol Myers Squibb
People and business resource groups - Bristol Myers Squibb
People and business resource groups Bristol Myers Squibb
Honoring oncologists through the Time Back campaign - Bristol Myers Squibb
Honoring oncologists through the Time Back campaign Bristol Myers Squibb
Bristol Myers Squibb acquires cell therapy biotech Orbital for $1.5bn - European Pharmaceutical R...
Bristol Myers Squibb acquires cell therapy biotech Orbital for $1.5bn European Pharmaceutical Review
BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future -...
BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future Fierce Biotech
WCLC25: BioNTech, BMS tout second readout for PD-L1/VEGF-A in SCLC - FirstWord Pharma
WCLC25: BioNTech, BMS tout second readout for PD-L1/VEGF-A in SCLC FirstWord Pharma
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover - BioSpace
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover BioSpace
How Bristol Myers Squibb Transformed Working Capital to Fund Its Future - Harvard Business Review
How Bristol Myers Squibb Transformed Working Capital to Fund Its Future Harvard Business Review
Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal - Fierce Pharma
Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal Fierce Pharma
With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis - F...
With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis Fierce Pharma
Clinical trials & studies - Bristol Myers Squibb
Clinical trials & studies Bristol Myers Squibb
Our science - Bristol Myers Squibb
Our science Bristol Myers Squibb
C2C4C marks 12 inspiring years advancing cancer research - Bristol Myers Squibb
C2C4C marks 12 inspiring years advancing cancer research Bristol Myers Squibb
BMS, Bain Capital team up on autoimmune-focused newco - FirstWord Pharma
BMS, Bain Capital team up on autoimmune-focused newco FirstWord Pharma
Bristol Myers Squibb Commits to Veeva Vault CRM - Veeva
BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes - Fierce Biotech
BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes Fierce Biotech
Merck & Co., BMS to lay off over 300 staffers in New Jersey - FirstWord Pharma
Merck & Co., BMS to lay off over 300 staffers in New Jersey FirstWord Pharma
BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study - BioSpace
BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study BioSpace
Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer t...
Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer test Fierce Biotech
BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC - BioSpace
BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC BioSpace
BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fier...
BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia Fierce Biotech
BMS bets on Janux’s novel solid tumour therapy through $850m deal - Yahoo Finance
BMS bets on Janux’s novel solid tumour therapy through $850m deal Yahoo Finance
Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future - McKinsey & Company
Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future McKinsey & Company
ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage tr...
ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage trial Fierce Biotech
Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma - Fierce Biotech
Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma Fierce Biotech
Our impact - Bristol Myers Squibb
Our impact Bristol Myers Squibb
BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates...
BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates BioSpace
BMS, Pfizer launch direct-to-consumer push for Eliquis in the US - FirstWord Pharma
BMS, Pfizer launch direct-to-consumer push for Eliquis in the US FirstWord Pharma
JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy - BioSpace
JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy BioSpace
BMS expands CAR-T portfolio with $1.5bn Orbital buyout - Pharmaceutical Technology
BMS expands CAR-T portfolio with $1.5bn Orbital buyout Pharmaceutical Technology
BMS sells controlling stake in historic US-China pharmaceutical joint venture - Fierce Pharma
BMS sells controlling stake in historic US-China pharmaceutical joint venture Fierce Pharma
Rovi’s injectables CDMO rebrands as Rois and acquires BMS facility - European Pharmaceutical Review
Rovi’s injectables CDMO rebrands as Rois and acquires BMS facility European Pharmaceutical Review
BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence - Fierce Biotech
BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence Fierce Biotech
Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS - Kaseya
Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS Kaseya
Pre-approval access to investigational medicines - Bristol Myers Squibb
Pre-approval access to investigational medicines Bristol Myers Squibb
Annual reports - Bristol Myers Squibb
Annual reports Bristol Myers Squibb
Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC - Fierce Biotech
Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC Fierce Biotech
In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy ...
In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy Fierce Pharma
Looking to the Future of Cell Therapy - Bristol Myers Squibb
Looking to the Future of Cell Therapy Bristol Myers Squibb
New BMS Department Head Makes Enthusiastic Return to Purdue to Take on New Leadership Role - Purd...
New BMS Department Head Makes Enthusiastic Return to Purdue to Take on New Leadership Role Purdue University College of Veterinary Medicine
BMS ups guidance, but its financial prospects fail to capture investor enthusiasm - FirstWord Pharma
BMS ups guidance, but its financial prospects fail to capture investor enthusiasm FirstWord Pharma
BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future - Fi...
BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future Fierce Pharma
BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO - FirstWord Pharma
BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO FirstWord Pharma
BMS to close Illinois site as part of cell therapy manufacturing consolidation - FirstWord Pharma
BMS to close Illinois site as part of cell therapy manufacturing consolidation FirstWord Pharma
2025 Annual Meeting of Shareholders - Bristol Myers Squibb
2025 Annual Meeting of Shareholders Bristol Myers Squibb
Post study drug access to BMS investigational medicinal products and approved products - Bristol ...
Post study drug access to BMS investigational medicinal products and approved products Bristol Myers Squibb
Bristol Myers, Pfizer offer Eliquis at a discount through DTC online program - Fierce Pharma
Bristol Myers, Pfizer offer Eliquis at a discount through DTC online program Fierce Pharma
Working at BMS - Bristol Myers Squibb
Working at BMS Bristol Myers Squibb
FDA Grants Fast Track Designation to BMS-986446 for Treatment of Early Alzheimer Disease - Pharma...
FDA Grants Fast Track Designation to BMS-986446 for Treatment of Early Alzheimer Disease Pharmacy Times
Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutati...
Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile ASM Journals
Policy shows how BMS MLB game qualifies for $4.8M grant - WJHL
Policy shows how BMS MLB game qualifies for $4.8M grant WJHL
BMS, RayzeBio launch radiopharmaceutical manufacturing site in Indianapolis - Fierce Pharma
BMS, RayzeBio launch radiopharmaceutical manufacturing site in Indianapolis Fierce Pharma
BioNTech, BMS tout first global data for PD-L1xVEGF bispecific in small cell lung cancer, set pha...
BioNTech, BMS tout first global data for PD-L1xVEGF bispecific in small cell lung cancer, set phase 3 dose Fierce Biotech
BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel ...
BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel UroToday
Déjà vu for Bristol Myers as it faces another anti-competition lawsuit over blockbuster Pomalyst ...
Déjà vu for Bristol Myers as it faces another anti-competition lawsuit over blockbuster Pomalyst Fierce Pharma
A bold blueprint for transforming lupus outcomes - Bristol Myers Squibb
A bold blueprint for transforming lupus outcomes Bristol Myers Squibb